Enanta Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$13.93

+0.21 (+1.53%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +219.8% upside

Low Target $33.16

Average Target $44.55

High Target $53.28

Current Price $13.93

Current
$13.93

Target
$44.55

$33.16 $44.55 avg $53.28

Scenario Analysis

Bear Case

$33.16

138.0%

Low target

Base Case

$44.55

+219.8%

Avg target

Bull Case

$53.28

+282.5%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$17.15

-18.8% from high

52-Week Low

$6.44

+116.5% from low

Target vs 52W High

$44.55

+159.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-46.4%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+191.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-36.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.5%